Molecular Weight of Urokinase [PDF]
Nature, 1965 UROKINASE is a proteolytic enzyme in human urine1. Its ability to activate plasminogen has stimulated interest in its potential clinical use as a thrombolytic agent.
Roger A. Burges +2 more
openalex +4 more sources
A case of complicated parapneumonic pleural effusion caused by paragonimus infection in a child was successfully treated by intrapleural injection of urokinase: a case report and literature review [PDF]
Frontiers in PediatricsObjectiveThe clinical data of a child with complex parapneumonic effusion (PPE) caused by pneumofluke infection were analyzed, and the diagnosis and treatment of the disease were discussed through literature review.
Yangyi Shi, Yan Li, Yu Hu
doaj +2 more sources
Journal of Biological Chemistry, 1986 Urokinase-related proteins were purified from 60-liter batches of human urine collected into the protease inhibitor aprotinin to prevent proteolytic degradation. Three homogeneous species were obtained by chromatography on zinc chelate-Sepharose, SP-Sephadex C-50, Sephadex G-100, benzamidine-Sepharose, and immunoadsorption on a murine anti-human ...
D C Stump, M Thienpont, Désiré Collen
openalex +4 more sources
A matters arising: discussion on urokinase dosing and individualized treatment strategies in the TRUST trial [PDF]
BMC MedicineThis matters arising addresses the recently published article in BMC Medicine by Tao Y et al., entitled “Effect of intravenous urokinase vs best medicine treatment on functional outcome for patients with acute minor stroke (TRUST): a randomized ...
Yue Qiao, Xunming Ji, Wenbo Zhao
doaj +2 more sources
Safety and efficacy of tirofiban after intravenous thrombolysis with urokinase in patients with acute ischemic stroke [PDF]
Frontiers in NeurologyIntroductionTirofiban combined with alteplase thrombolysis or endovascular therapy has been proven to improve the prognosis of patients with acute ischemic stroke (AIS).
Dian Qu +7 more
doaj +2 more sources
Treatment with urokinase. [PDF]
British Journal of Ophthalmology, 1977 Wc H, Tavistock Square, London
openalex +4 more sources
Efficacy of YL-1 hematoma crushing needle combined with hematoma drainage in intracerebral hemorrhage treatment [PDF]
Frontiers in MedicineObjectiveEarly craniotomy evacuation in hematoma surgery does not significantly improve the prognosis of patients with spontaneous intracerebral hemorrhage (ICH).
Xianyong Chen +5 more
doaj +2 more sources
Intravenous Thrombolysis with Urokinase for Acute Ischemic Stroke [PDF]
Brain SciencesBackground: Intravenous thrombolysis is one of the most effective therapies for the treatment of acute ischemic stroke (AIS), with urokinase offering a cost-effective alternative to newer agents like alteplase and tenecteplase, especially in resource ...
Yue Qiao +5 more
doaj +2 more sources
Efficacy and safety of catheter-directed thrombolytic therapy of alteplase and urokinase for the treatment of deep vein thrombosis: a Meta-analysis [PDF]
Yixue xinzhi zazhi, 2023 Objective To systematically review the effectiveness and safety of cathe-ter-directed thrombolytic therapy (CDT) using alteplase and urokinase in the treatment of deep vein thrombosis (DVT) in the lower extremities.Method PubMed, The Cochrane Library ...
Hong-Yan LI +6 more
doaj +1 more source
Fibrinolysis with Lower Dose Urokinase in Patients with Complicated Parapneumonic Effusion [PDF]
Tuberculosis and Respiratory Diseases, 2021 Background Intrapleural urokinase is one of the most widely used fibrinolytic agents in the treatment of complicated parapneumonic effusion (CPPE). However, little research has been performed on the optimal urokinase dosage.
Seul Lee +8 more
doaj +1 more source